PMID:20953154

Data sourced from Pubmed

May 27, 2024, 8:45 p.m.

Molecular and structural characterization of the L1 virus-like particles that are used as vaccine antigens in Cervarix™, the AS04-adjuvanted HPV-16 and -18 cervical cancer vaccine.

Deschuyteneer M, Elouahabi A, ... , Deschamps M

2010 in Human vaccines

Status	Created By	Created At	Updated At	Team	Gene Product	GO Term	Evidence	Reference	Accepted Curator
	legacy-curator	Sept. 14, 2013, midnight	Aug. 23, 2024, 9:40 p.m.	—	P03101	GO:0039620	ECO:0000315	20953154	Aajones4	View